Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/4028027

Download in:

View as

General Info

PMID
4028027